当前位置: 首页 > 详情页

Prognostic significance of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage I lung adenocarcinoma: A retrospective study based on analysis of 110 Chinese patients

| 导出 | |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China [2]Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, China
出处:
ISSN:

关键词: IASLC ATS ERS classification non-small cell lung cancer prognosis

摘要:
BackgroundThe aim of this study was to investigate the relationship between predominant subtype, classification, and prognosis in Chinese stage I lung adenocarcinoma patients according to the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) International Multidisciplinary Lung Adenocarcinoma Classification. MethodsBetween 2000 and 2010, 110 patients with stage I lung adenocarcinoma underwent surgery at Xuanwu Hospital. Two pathologists independently reclassified all resected specimens according to the IASLC/ATS/ERS classification. Survival curves were plotted using the Kaplan-Meier method. The Cox proportional hazard model was used for multivariate analysis. ResultsThere were no cases of adenocarcinoma in situ, and three cases of minimally invasive adenocarcinoma. There were 107 cases of invasive adenocarcinoma: 12 lepidic, 32 acinar, 30 papillary, 18 micropapillary, and 15 solid predominant subtypes. Patients with micropapillary and solid predominant tumors had significantly poorer disease-free survival compared to those with other subtypes of predominant tumors (P=0.021). Multivariate analysis revealed that the new classification (P=0.003) and T stage (P=0.034) were independent predictors of disease-free and overall survival, respectively. ConclusionThe predominant subtype in the primary tumor was associated with prognosis in resected stage I lung adenocarcinoma.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 呼吸系统
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 呼吸系统
JCR分区:
出版当年[2015]版:
Q4 ONCOLOGY Q4 RESPIRATORY SYSTEM
最新[2023]版:
Q2 RESPIRATORY SYSTEM Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
通讯作者:
通讯机构: [*1]Department of Thoracic Surgery, Xuanwu Hospital, No. 45 Changchunjie, Xicheng District, Beijing 100053, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17005 今日访问量:0 总访问量:906 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院